 |
|
|
|
T291
Multiple myeloma test tissue array, with normal bone marrow tissue as control, 6 cases/24 cores, replaced by T291a
|
|
| Microarray Panel: | Multiple myeloma tissue microarray, containing 4 cases myeloma and 2 normal bone marrow tissue, quadruple cores per case, divided into two identical 12 core arrays for testing different antibody dilutions |
| Cores: | 24 |
|
| Cases: | 6 |
| Layout: | 8 cols × 3 rows |
| Core Diameter: | 1.5 mm |
| Thickness: | 5 µm | | Quality Control: | Anti-Actin confirmed | | Applications: | Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page. |
| Notes: | Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure. |
*Tissue Microarray Slide Types:
- Unstained: unstained
paraffin
tissue microarray slide.
- Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
- H & E: Hematoxylin and Eosin stained tissue microarray slide.
Specification Sheet
| Pos |
No. |
Sex |
Age |
Organ |
Pathology diagnosis |
Type † |
|
A1 |
1 |
M |
57 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
A2 |
2 |
M |
57 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
A3 |
3 |
M |
57 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
A4 |
4 |
M |
57 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
A5 |
5 |
M |
57 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
A6 |
6 |
M |
57 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
A7 |
7 |
M |
57 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
A8 |
8 |
M |
57 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
B1 |
9 |
F |
43 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
B2 |
10 |
F |
43 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
B3 |
11 |
M |
44 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
B4 |
12 |
M |
44 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
B5 |
13 |
F |
43 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
B6 |
14 |
F |
43 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
B7 |
15 |
M |
44 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
B8 |
16 |
M |
44 |
Bone marrow |
Plasma cell myeloma |
Malignant |
|
C1 |
17 |
M |
35 |
Bone marrow |
Normal bone marrow tissue |
Normal |
|
C2 |
18 |
M |
35 |
Bone marrow |
Normal bone marrow tissue |
Normal |
|
C3 |
19 |
F |
21 |
Bone marrow |
Normal bone marrow tissue |
Normal |
|
C4 |
20 |
F |
21 |
Bone marrow |
Normal bone marrow tissue |
Normal |
|
C5 |
21 |
M |
35 |
Bone marrow |
Normal bone marrow tissue |
Normal |
|
C6 |
22 |
M |
35 |
Bone marrow |
Normal bone marrow tissue |
Normal |
|
C7 |
23 |
F |
21 |
Bone marrow |
Normal bone marrow tissue |
Normal |
|
C8 |
24 |
F |
21 |
Bone marrow |
Normal bone marrow tissue |
Normal |
|
–
|
– |
M |
58 |
Skin |
Malignant melanoma (tissue marker) |
Malignant |
† For precise diagnosis, refer to pathology description.
|
|
